Showing 1–12 of 16 results

  • Zydus Cadila has won approval for its saroglitazar to be used as the treatment of non-cirrhotic nonalcoholic steatohepatitis (NASH) in India.
  • The green light from the Drug Controller General of India (DCGI) makes saroglitazar the first drug in the world approved for this indication.